SlideShare a Scribd company logo
1 of 72
Virology Review
Just the basics!
Diagnostic techniques used in
the Virology Laboratory
Laboratory diagnosis
 Direct antigen detection from lesions
 Direct Fluorescent antibody (DFA) stain
 Collect cells from base of vesicular lesion
 Stain with Fl antibody specific for HSV and/or VZV


Look for fluorescent cells
using fluorescence
microscope

 Can provide a HSV and VZV diagnosis
 More sensitive and specific than Tzanck prep
(DFA 80% vs. Tzanck 50%)
 Tzanck prep= Giemsa stain/examine for
multinucleated giant cells of Herpes virus
Tzanck
Rapid detection of viral antigens
 Enzyme immunoassay –
 Antigen/antibody complex formed – then
combined with color forming compound
 Detection of non-culturable viruses – such
as Rotavirus
 Detection of Influenza A and B , and
Respiratory syncytial virus (RSV)

 Membrane EIA

Liquid/well EIA
Molecular Detection
 Amplification of DNA or RNA
 Rapid results
 Exceed sensitivity of culture
 Standard of practice for detecting respiratory viruses

 Standard of practice for HSV and Enterovirus
detection in CSF
 Culture <=20%

PCR >=90%

 CMV quantitative assays in transplantation
 Hepatitis B and C detection and viral load
 HIV viral load
 Test of diagnosis not cure – can retain DNA/RNA
for 7 – 30 days after initial diagnosis
Viral Cell Culture
 Viral cell culture
 Inner wall coated with monolayer of cells
covered with liquid maintenance media
 Primary cell lines – directly from animal
into tube (Rhesus monkey kidney-RMK)
 Diploid cell lines– Can survive 20 – 50
passes into new vials – fibroblast cells
MRC-5-(Microbiology Research Council 5)
human diploid fibroblasts
 Continuous cell lines – can survive
continuous passage into new vials, usually
of tumor lineage, HEp-2 and HeLa
Viral Cell culture
 Cytopathic effect – CPE
 Appearance of cell monolayer after being
infected with a virus
 Specific for each virus type
Spin Down Shell Vial Method

Designed to speed up virus recovery
Cells are on the round coverslip
Specimen put into vial
Centrifugation to induce virus invasion
Incubate 24 - 72 hours
DFA stain cells on coverslip with early
antigen for virus of interest

Cover slip
Specimen collection and
transport
 Viral transport media- Hanks balanced salt
solution with antibiotics, needed for the
transport of lesions, mucous membranes and
throats to the laboratory
I
Which viruses will survive the trip
to the laboratory?
 Most likely viable - HSV
 Intermediate
 Adenovirus
 Influenza A and B
 Enterovirus
 Least likely to survive
 Respiratory Syncytial Virus (RSV)
 Cytomegalovirus (CMV)
 Varicella Zoster virus (VZV)
 Amplification preferred due to survival issue
Which viruses grow the fastest in
conventional cell culture?
 Fast (>=24 hours)
 HSV
 Intermediate (5 -7 days)
 Adenovirus
Enterovirus
 Influenzae
VZV
 Slow (10 - 14 days)
 RSV
 Slowest (14 - 21 days)
 CMV

 Molecular superior for slow growers
Herpesviridae
Herpes Viruses
 Double stranded DNA virus
 Eight human Herpes viruses
 Herpes simplex 1
 Herpes simplex 2
 Varicella Zoster
 Epstein Barr
 Cytomegalovirus
 Human Herpes 6, 7, and 8
 Latent infection with recurrent disease is the
hallmark of the Herpes viruses
 Latency occurs within small numbers of specific kinds
of cells, the cell type is different for each Herpes virus
Herpes simplex virus 1 and 2
 Transmission: direct contact/secretions
 Latency: dorsal root ganglia *
 Disease –
 Gingivostomatitis
 Herpes labialis
 Ocular
 Encephalitis
 Neonatal
 Disseminated in immune suppressed

 Therapy – Acyclovir, Valacyclovir
Herpes virus diagnosis
Herpes 1 & 2 do well in culture
Grow within 24-48 hrs in Human diploid fibroblast cells
(MRC-5) / Observe for characteristic CPE

 Antigen detection by direct fluorescent staining
of cells obtained from vesicular lesions
 Amplification methods for diagnosis
 Cytology/Histology - intra nuclear inclusions,
multinucleated giant cells
 Serology – Most helpful to detect past infection
Negative fibroblast cell
Culture -uninfected cells

HSV infected monolayer
Rounded cells throughout
the monolayer in cell culture

Multinucleated Giant Cells
of Herpes Simplex in tissue
histology
Varicella Zoster Virus
 Transmission: close contact
 Latency: dorsal root ganglia
 Diseases:
 Chickenpox (varicella)
 Shingles (zoster – latent infection)

 Chicken pox +/- eliminated due to effective
vaccine program – most serious disease occurs in
immune suppressed or adult patient – can progress to
pneumonia and encephalitis

 Histology –

Herpes simplex

multi-nucleated giant cells like those of

 Serology useful for immune status check
 Amplification useful for disease diagnosis
Varicella-Zoster Diagnosis
In cell culture –
Limited # of Foci
5- 7 days to develop
Sandpaper look to the
Background
Scattered rounded cells

Younger wet vesicular lesions area
the best for culture and/or
molecular testing
Cytomegalovirus (CMV)
 Transmitted by blood transfusion , vertical and
horizontal transmission to fetus, close contact
 Latency: Macrophages
 Disease: Asymptomatic in most individuals infected

 Congenital – most common cause
 Perinatal
 Immunocompromised – Primary disease most
serious

 Diagnosis: Cell culture CPE (Human diploid fibroblast ,
PCR and quantitative PCR
 Histopathology: Intranuclear and
intracytoplasmic inclusions
“Owl Eye” Inclusions
CMV pneumonia with
viral inclusions

CMV infected fibroblast
monolayer - Focal grape like
clusters of rounded cells
Epstein Barr virus (EBV)
 Transmission - close contact, saliva
 Latency - B lymphocytes
 Diseases include:
 Infectious mononucleosis
 Lymphoreticular disease
 Oral hairy leukoplakia
 Burkitt’s lymphoma
 Nasopharyngeal Carcinoma
 1/3 Hodgkin’s lymphoma
 Unable to grow in cell culture
 Serology and PCR methods for diagnosis
EBV Serodiagnosis using the
Heterophile Antibody
 Heterophile antibodies (HA) react with
antigens phylogenetically unrelated to the
antigenic determinants against which they
were raised
 HA secondary to EBV are detected by the
ability to react with horse or cattle rbcs
(theory of the Monospot test)
 HA rise in the first 2 - 3 weeks of EBV
infection, then rapidly fall at @ 4 weeks
 Cannot be used in children < 4 years of age
VCA = viral capsid antibody
EBNA = Epstein Barr nuclear antigen
EA = early antigen
Human Herpes virus
6, 7 & 8
 HH6
 Roseola [sixth disease]
 6m-2yr high fever & rash

 HH7
 CMV like Disease

 HH8
 Kaposi’s sarcoma
 Castleman’s disease

Onion skin of
Castleman disease
Adenovirus
Adenovirus





DNA - non enveloped/ icosahedral virus
Latent: lymphoid tissue
Transmission: Respiratory and fecal-oral route
Diseases:
 Adenovirus type 14 – new virulent
respiratory strain / pneumonia
 Pharyngitis (year round epidemics)
 Gastroenteritis in children
 Adenovirus types 40 & 41

 Keratoconjuctivitis
 Disseminated infection in transplant patients
 Hemorrhagic cystitis in immune suppressed
Adenovirus

Round cells with
stranding

 Diagnosis
 Conventional cell culture (CPE)

 2-5 days with round cells connected by
strands – Grows best in Heteroploid
continuous passage cell lines (HeLA, Hep-2)
 Amplification
 Histology - Intranuclear inclusions / smudge cells
 Stool EIA for enteric infections
 Antigen detection – staining respiratory cells by DFA
for Respiratory infections
 PCR – has become the standard of practice
 Supportive treatment – no specific viral therapy
Smudge cells- Adenovirus
Parvoviridae – Parvovirus
The smallest known viruses!
Parvovirus
 DNA virus
 Parvovirus B19

Slapped face appearance
of fifth disease

 erythema infectiosum (Fifth disease)
 fetal infection and stillbirths
 aplastic crisis in patients with chronic hemolytic
anemia and AIDS
 Histology - virus effects
mitotically active erythroid
precursor cells in bone marrow
 Molecular and Serology methods
for diagnosis
Papovaviridae
Papillomavirus
Polyomavirus

Infectious and oncogenic or
potentially oncogenic DNA
viruses
Pap smear

Papillomavirus
 Diseases:











skin and anogenital warts,
benign head and neck tumors,
cervical and anal intraepithelial neoplasia and cancer

HPV types 16 and 18 = 70% Cervical CA
HPV types 6 and 11 = 90% Genital warts
Pap Smear for detection
Hybrid capture DNA probe for detection and typing
PCR – FDA approved platforms for detection/typing
Guardasil vaccine = To guard against HPV 6,11,16,18
Polyomavirus

Giant Glial Cells of JCV

 JC virus [John Cunningham]
 Cause of Progressive multifocal
leukoencephalopathy 


Encephalitis of immune
suppressed
Destroys oligodendrocytes
in brain

 BK virus
 Causes latent virus infection in kidney
 Progression due to immune suppression
 Hemorrhagic cystitis
 Histology/PCR for diagnosis
Hepadnavirus

Hepatitis B
Hepatitis B virus





Enveloped DNA – Hepadna virus
Virion called Dane particle
Surface Ag (HBsAg)- Australian Ag
Clinical Disease
 90% acute
 1% fulminant
 9% chronic
 Carrier state …….Hepatic cell carcinoma
Hepatitis B Serology
 Surface Antigen Positive
 Active Hepatitis B or Chronic Carrier

 Do Hep B Quantitation
 Do Hep e antigen – Chronic and “bad”

 Core Antibody Positive
 Immune due to prior infection, acute infection or
chronic carrier

 Surface Antibody Positive
 Immune due to prior infection or vaccine
Flaviviridae
RNA Viruses

Hepacivirus
Hepatitis C
Flavivirus
West Nile
Dengue
Yellow Fever
Hepatitis C virus
 Spread parenterally - drug abuse, blood products,
poorly sterilized medical equipment, sexual
 Effects only humans and chimpanzees
 Seven major genotypes
 Acute self limited disease to start with progressive
disease that mainly affects the liver
 Infection persists in 80%
 20 - 30 % develop cirrhosis
 Associated with hepatocellular CA
 Require liver transplantation
Hepatitis C
 Diagnosis:
 Hep C antibody test
 If antibody positive do:
 RNA qualitative or quantitative assay for
viral load
 Requires Genotyping for proper therapy
 Type 1 most common

 No vaccine – Antivirals currently in clinical trials
that can cure a large % of infected
Flaviviruses – Mosquito borne
 St. Louis
 Dengue – breakbone fever
 Yellow fever
 West Nile
Fever, Headache, Muscle weakness
Various species Mosquitoes

 Serology / PCR
Picornaviridae

Enteroviruses
Hepatitis A
Enteroviruses
 Diverse group of > 60 viruses


infections occur most often in summer and fall

 Polio virus - paralysis








 Salk vaccine Inactive Polio Vaccine (IPV)**
 Sabine vaccine Live Attenuated Vaccine (OPV)
Coxsackie A – Herpangina
Coxsackie B – Pericarditis/Myocarditis
Enterovirus – Aseptic meningitis in children,
hemorrhagic conjunctivitis
Echovirus – various infections, intestine
Rhinoviruses – common cold
Grow in cell culture (Diploid mixed cell – Primary
Monkey Kidney)
PCR superior for diagnosis of meningitis (CSF)
CPE of Enterovirus
Teardrop and kite like cells in
Rhesus Monkey Kidney cell culture
Hepatitis A
 Fecal – oral transmission
 Can be cultured but not reliably
 Usually – short incubation, abrupt onset, low mortality,
no carrier state
 Travel
 Diagnosis – serology, IgM positive in early infection
 Vaccine available
Orthomyxoviruses
Influenza virus A
Influenza virus B
Influenza A
 Segmented RNA genome
 Hemagglutinin and Neuraminidase glycoproteins spikes
on outside of viral capsid


Give Influenza A the H and N designations – such as H1N1
and H3N2

 Antigenic drift - minor change in the amino acids of
either the H or N glycoprotein
 Cross antibody protection will still exist so an
epidemic will not occur

 Antigenic shift - genome re assortment with a “new”
virus created/usually from a bird or animal/ this
could create a potential pandemic

 H5N1 = Avian Influenza
 H1N1 = 2009 Influenza A
Influenzae A
Disease: fever, malaise …. death
Diagnosis
 Cell culture obsolete [RMK]
 Enzyme immunoassay on paper membrane can be
used in outpatient setting – Rapid but low sensitivity
(60%) and can have specificity issues in off season.
 Amplification (PCR) gold standard for Influenza
Detection
 Treatment: Amantadine and Tamiflu
 Seasonal variation in susceptibility
 Vaccinate to prevent

 Influenza B



Milder form of Influenza like illness
Usually <=10% of cases /year
Paramyxoviruses – SS RNA
Measles
Parainfluenza 1,2,3,4
Mumps
Respiratory Syncytial Virus
Human Metapneumovirus
Measles
 Measles
 Fever, Rash, Dry Cough, Runny Nose,
Sore throat, inflamed eyes (photosensitive)
 Respiratory spread - very contagious
 Koplik’s spots – bluish discoloration inner
lining of the cheek
 Subacute sclerosing panencephalitis [SSPE]
 Rare chronic degenerative neurological disease
 Persistent infection with mutated measles virus
due to lack of immune response
 Diagnosis: Clinical symptoms and Serology
 Vaccinate – MMR (Measles, Mumps, Rubella) vaccine
 Treatment: Immune globulin, vitamin A
Parainfluenzae
 Types 1,2,3, and 4
 Person to person spread
 Disease:
 Upper respiratory tract infection in adults –
more serious in immune suppressed
 Croup, bronchiolitis and pneumonia in
children
 Heteroploid cell lines (Hep-2) for culture
 PCR methods are the gold standard
 Supportive therapy
Mumps
 Person to person contact
 Classic infection is Parotitis, but can
cause infections in other sites:
T
Respiratory Syncytial Virus
 Transmission:
 Hand contact and respiratory droplets
 Respiratory disease - from common cold to
pneumonia, bronchiolitis to croup, serious
disease in immune suppressed
 Classic disease:
 Young infant with bronchiolitis
 Specimen: Naso-phayrngeal, nasal swab,
nasal lavage
 Diagnosis: EIA, cell culture (heteroploid cell
lines), PCR is standard practice
 Treatment: Supportive, ribavirin
Classic CPE = Syncytium formation
In heteroploid cell line
Respiratory syncytial virus CPE

Histology
Human Metapneumovirus
 1st discovered in 2001 – community acquired
respiratory tract disease in the winter
 Common in young children – but can be seen in all
age groups
 @95% of cases in children <6 years of age
 Upper respiratory tract disease
 2nd only to RSV in the cause of bronchiolitis
 Will not grow in cell culture
 Amplification (PCR) for detection
 Specimen: Nasal swab or NP
 Treatment: Supportive
Reoviridae
Rotavirus
Rotavirus
 Winter - spring season
 6m-2 yrs of age,
 Gastroenteritis with vomiting and fluid loss –
most common cause of severe diarrhea in
children
 Fecal – oral spread
 Major cause of death in 3rd world
 Diagnosis – cannot grow in cell culture
 Enzyme immunoassay, PCR
 Vaccine available
Calciviruses
Norovirus
Norovirus
 Spread by contaminated food and water, feces
& vomitus – takes <=20 virus particles to
cause infection – so highly contagious
 Tagged the “Cruise line virus” – numerous
reported food borne epidemics on land and sea
 Leading cause of epidemic gastroenteritis –
more virulent GII.4 Sydney since spring 2012
 Fluid loss from vomiting
 Disease course usually limited, 24-48 hours
 PCR for diagnosis
 Cannot be grown in cell culture
Retrovirus
RNA Virus/Reverse Transcriptase Enzyme

Human Immunodeficiency Virus
HIV
Human Immunodeficiency virus
 CD4 primary receptor to gain
entry for HIV into the lymphocyte
 Reverse transcriptase enzyme
converts genomic RNA into DNA
 Transmission - sexual, blood and blood product
exposure, perinatal
 Non infectious complications:
 Lymphoma, KS, Anal cell CA, non Hodgkins
Lymphoma
HIV
 Diagnosis

 Antibody EIA with Western Blot confirmation
 Antibody test alone is NOT sufficient
 Western blot detects gp160/gp120 (envelope
proteins), p 24 (core), and p41(reverse trans)
 Must have at least 2 bands on Western blot to
confirm the diagnosis of HIV
 Positive patients require additional testing
 HIV RNA/DNA quantitation >= 100 copies
 Resistance Testing – report subtype
 Most isolates in USA type B

 Monitor CD4 counts for infection severity
HIV infectious complications
 Non-compliant patients or newly diagnosed








Pneumocystis
C. neoformans and Histoplasma
TB/Mycobacterium avium complex
Microsporidia and Cryptosporidium
Hepatitis B
Hepatitis C
STD’s – Syphilis, GC, Chlamydia
 Syphilis rate high (mucosal contact)
Togaviridae
RNA Virus
Rubella
Rubella
 Respiratory transmission
 Known as the “Three day measles” – German measles
 Congenital rubella – occurs in a developing fetus of a
pregnant women who has contracted Rubella, highest
% in the first trimester pregnancy
 Diagnosis - Serology in combination with clinical
symptoms – Rash, low fever, cervical
lymphadenopathy
 Live attenuated vaccine (MMR) to prevent
Bunyaviridae

enveloped RNA viruses

Hantavirus
Hantavirus
 USA outbreak in four corners (NM,AZ,CO,UT)
Indian reservation in 1993 brought attention to
this virus
 Source - Urine and secretions of wild field mice
 Deer mouse and cotton rat
 Myalgia, headache, cough and respiratory
failure
 Found in states west of the Mississippi River
 Diagnosis by serology/ no therapy
Poxviruses
Smallpox virus (Variola virus)
Vaccinia virus
Smallpox
 Smallpox virus is also known as the Variola virus
 Vaccinia virus = vaccine strain used in Smallpox
vaccine, it is immunologically related to smallpox,
Vaccinia can cause disease in the immune
suppressed, which prevents vaccinated this population
 Last case of Smallpox - Somalia in 1977
 Disease begins as maculopapular rash and progresses
to vesicular rash - all lesions in same stage on a body
area – rash moves from central body outward
 Potential agent of Bioterrorism
 Any potential cases directly reported to public health
department – they will investigate and diagnose
Chickenpox vs Smallpox lesions
Chicken pox – Lesions of
different stage of development

Smallpox – all lesions same
stage of development
Rhabdoviruses

bullet shaped RNA virus

Rabies virus
Rabies
 Worldwide in animal populations
 Bat and raccoons primary reservoir in US
 Dogs in 3rd world countries
 Post exposure shots PRIOR to the development of
symptoms prevent infection
 Rabies is a neurologic disease – classic sympton is
salivation, due to paralysis of throat muscles
 Detection of viral particles in the brain by Histologic
staining known as Negri bodies
 Public health department should be contacted to assist
with diagnosis
Rabies virus particles
EM showing the bullet
shaped virus

Negri bodies –
intracytoplasmic

More Related Content

What's hot

07 pathogenicity and_virulence
07 pathogenicity and_virulence07 pathogenicity and_virulence
07 pathogenicity and_virulenceMUBOSScz
 
Human Immunodeficiency Virus
Human Immunodeficiency VirusHuman Immunodeficiency Virus
Human Immunodeficiency Viruspromotemedical
 
Chapter 5 identification of virus
Chapter 5 identification of virusChapter 5 identification of virus
Chapter 5 identification of virusAlia Najiha
 
Laboratory diagnosis of viral infection
Laboratory diagnosis of viral infectionLaboratory diagnosis of viral infection
Laboratory diagnosis of viral infection9925752690
 
Mechanism of bacterial pathogenesis and virulence
Mechanism of bacterial  pathogenesis  and virulenceMechanism of bacterial  pathogenesis  and virulence
Mechanism of bacterial pathogenesis and virulenceMeher Rizvi
 
Baltimore classification of viruses presentation
Baltimore classification  of viruses presentationBaltimore classification  of viruses presentation
Baltimore classification of viruses presentationtheophilus74
 
HISTORY & DEVELOPMENT OF MEDICAL MICROBIOLOGY
HISTORY & DEVELOPMENTOFMEDICAL MICROBIOLOGYHISTORY & DEVELOPMENTOFMEDICAL MICROBIOLOGY
HISTORY & DEVELOPMENT OF MEDICAL MICROBIOLOGYSaajida Sultaana
 
Baltimore classification virus
Baltimore classification  virusBaltimore classification  virus
Baltimore classification virusSuganyaPaulraj
 
Bacterial virulence factors
Bacterial virulence factorsBacterial virulence factors
Bacterial virulence factorsAhmed Mohamed
 
Serological test for virus identification
Serological test for virus identificationSerological test for virus identification
Serological test for virus identificationPlock Ghosh
 
Nosocomial infection & control
Nosocomial infection & controlNosocomial infection & control
Nosocomial infection & controlKalpesh Zunjarrao
 
01.02 biology of hiv
01.02  biology of hiv01.02  biology of hiv
01.02 biology of hivDavid Ngogoyo
 
MOLECULAR TOOLS IN DIAGNOSIS AND CHARACTERIZATION OF INFECTIOUS DISEASES
MOLECULAR TOOLS IN  DIAGNOSIS AND CHARACTERIZATION OF INFECTIOUS DISEASES MOLECULAR TOOLS IN  DIAGNOSIS AND CHARACTERIZATION OF INFECTIOUS DISEASES
MOLECULAR TOOLS IN DIAGNOSIS AND CHARACTERIZATION OF INFECTIOUS DISEASES tawheedshafi
 

What's hot (20)

07 pathogenicity and_virulence
07 pathogenicity and_virulence07 pathogenicity and_virulence
07 pathogenicity and_virulence
 
Picornavirus
PicornavirusPicornavirus
Picornavirus
 
Virology
VirologyVirology
Virology
 
Rhabdo virus
Rhabdo virusRhabdo virus
Rhabdo virus
 
Human Immunodeficiency Virus
Human Immunodeficiency VirusHuman Immunodeficiency Virus
Human Immunodeficiency Virus
 
Chapter 5 identification of virus
Chapter 5 identification of virusChapter 5 identification of virus
Chapter 5 identification of virus
 
Laboratory diagnosis of viral infection
Laboratory diagnosis of viral infectionLaboratory diagnosis of viral infection
Laboratory diagnosis of viral infection
 
Mechanism of bacterial pathogenesis and virulence
Mechanism of bacterial  pathogenesis  and virulenceMechanism of bacterial  pathogenesis  and virulence
Mechanism of bacterial pathogenesis and virulence
 
Baltimore classification of viruses presentation
Baltimore classification  of viruses presentationBaltimore classification  of viruses presentation
Baltimore classification of viruses presentation
 
HISTORY & DEVELOPMENT OF MEDICAL MICROBIOLOGY
HISTORY & DEVELOPMENTOFMEDICAL MICROBIOLOGYHISTORY & DEVELOPMENTOFMEDICAL MICROBIOLOGY
HISTORY & DEVELOPMENT OF MEDICAL MICROBIOLOGY
 
Rhabdovirus
RhabdovirusRhabdovirus
Rhabdovirus
 
Baltimore classification virus
Baltimore classification  virusBaltimore classification  virus
Baltimore classification virus
 
Aspergillus
AspergillusAspergillus
Aspergillus
 
Bacterial virulence factors
Bacterial virulence factorsBacterial virulence factors
Bacterial virulence factors
 
Serological test for virus identification
Serological test for virus identificationSerological test for virus identification
Serological test for virus identification
 
Nosocomial infection & control
Nosocomial infection & controlNosocomial infection & control
Nosocomial infection & control
 
01.02 biology of hiv
01.02  biology of hiv01.02  biology of hiv
01.02 biology of hiv
 
MOLECULAR TOOLS IN DIAGNOSIS AND CHARACTERIZATION OF INFECTIOUS DISEASES
MOLECULAR TOOLS IN  DIAGNOSIS AND CHARACTERIZATION OF INFECTIOUS DISEASES MOLECULAR TOOLS IN  DIAGNOSIS AND CHARACTERIZATION OF INFECTIOUS DISEASES
MOLECULAR TOOLS IN DIAGNOSIS AND CHARACTERIZATION OF INFECTIOUS DISEASES
 
Poxviruses
PoxvirusesPoxviruses
Poxviruses
 
HISTOPLASMOSIS.pptx
HISTOPLASMOSIS.pptxHISTOPLASMOSIS.pptx
HISTOPLASMOSIS.pptx
 

Viewers also liked

Viewers also liked (20)

Virology 2016
Virology 2016Virology 2016
Virology 2016
 
Virology Update 2017
Virology Update 2017Virology Update 2017
Virology Update 2017
 
Mycology Update 2017
Mycology Update 2017Mycology Update 2017
Mycology Update 2017
 
Mycology 2016
Mycology 2016Mycology 2016
Mycology 2016
 
Parasitology Review
Parasitology ReviewParasitology Review
Parasitology Review
 
Virology - Prac. Microbiology
Virology - Prac. MicrobiologyVirology - Prac. Microbiology
Virology - Prac. Microbiology
 
Website mycobacteriology 2017 update
Website  mycobacteriology 2017 updateWebsite  mycobacteriology 2017 update
Website mycobacteriology 2017 update
 
Laboratory diagnosis of viral infection
Laboratory diagnosis of viral infectionLaboratory diagnosis of viral infection
Laboratory diagnosis of viral infection
 
Mycobacteriology 2016
Mycobacteriology 2016Mycobacteriology 2016
Mycobacteriology 2016
 
Virology
VirologyVirology
Virology
 
33. introduction to virology
33. introduction to virology33. introduction to virology
33. introduction to virology
 
Virology
VirologyVirology
Virology
 
Virology lecture #1 - What is a virus?
Virology lecture #1 - What is a virus?Virology lecture #1 - What is a virus?
Virology lecture #1 - What is a virus?
 
infectious hepatitis
 infectious hepatitis infectious hepatitis
infectious hepatitis
 
Test and Treat: The Gardner Cascade in Context
Test and Treat:  The Gardner Cascade in ContextTest and Treat:  The Gardner Cascade in Context
Test and Treat: The Gardner Cascade in Context
 
Parasitology Review 2017
Parasitology Review 2017Parasitology Review 2017
Parasitology Review 2017
 
Viral Transport Medium
Viral Transport MediumViral Transport Medium
Viral Transport Medium
 
Bacteriology 2017 Update
Bacteriology 2017 UpdateBacteriology 2017 Update
Bacteriology 2017 Update
 
Juan-Rodriguez-SCIA-AutismOne-2013 (1)
Juan-Rodriguez-SCIA-AutismOne-2013 (1)Juan-Rodriguez-SCIA-AutismOne-2013 (1)
Juan-Rodriguez-SCIA-AutismOne-2013 (1)
 
clasificacion de virus
clasificacion de virusclasificacion de virus
clasificacion de virus
 

Similar to Virology Review

Similar to Virology Review (20)

Virology 2014
Virology 2014Virology 2014
Virology 2014
 
Virology Review 2020
Virology Review 2020Virology Review 2020
Virology Review 2020
 
Virology 2018
Virology 2018Virology 2018
Virology 2018
 
Virology Review 2019
Virology Review 2019Virology Review 2019
Virology Review 2019
 
Virology 2021
Virology 2021Virology 2021
Virology 2021
 
Virology 2022
Virology 2022Virology 2022
Virology 2022
 
Viral Haemorrhagic Fevers
Viral Haemorrhagic FeversViral Haemorrhagic Fevers
Viral Haemorrhagic Fevers
 
Human cmv in immuncompromised and congential patients 2019
Human cmv in immuncompromised and congential patients  2019Human cmv in immuncompromised and congential patients  2019
Human cmv in immuncompromised and congential patients 2019
 
Viro
ViroViro
Viro
 
Viro
ViroViro
Viro
 
Virology 2024 | Microbes with Morgan 2024
Virology 2024 | Microbes with Morgan 2024Virology 2024 | Microbes with Morgan 2024
Virology 2024 | Microbes with Morgan 2024
 
VIROLOGY REVIEW 2023
VIROLOGY REVIEW 2023VIROLOGY REVIEW 2023
VIROLOGY REVIEW 2023
 
viral hepatitis.pdf
viral hepatitis.pdfviral hepatitis.pdf
viral hepatitis.pdf
 
Bohomolets Microbiology Lecture #14
Bohomolets Microbiology Lecture #14Bohomolets Microbiology Lecture #14
Bohomolets Microbiology Lecture #14
 
Reorhabdogit
ReorhabdogitReorhabdogit
Reorhabdogit
 
Reorhabdogit
ReorhabdogitReorhabdogit
Reorhabdogit
 
Bohomolets Microbiology Lecture #13
Bohomolets Microbiology Lecture #13Bohomolets Microbiology Lecture #13
Bohomolets Microbiology Lecture #13
 
Hepatitis ppt final
Hepatitis ppt finalHepatitis ppt final
Hepatitis ppt final
 
Viral tests
Viral testsViral tests
Viral tests
 
Hepatitis
HepatitisHepatitis
Hepatitis
 

More from Margie Morgan

Susceptibility Update 2024 | Microbes with Morgan
Susceptibility Update 2024 | Microbes with MorganSusceptibility Update 2024 | Microbes with Morgan
Susceptibility Update 2024 | Microbes with MorganMargie Morgan
 
WEB BACTERIOLOGY 2024 | Microbes With Morgan
WEB BACTERIOLOGY 2024 | Microbes With MorganWEB BACTERIOLOGY 2024 | Microbes With Morgan
WEB BACTERIOLOGY 2024 | Microbes With MorganMargie Morgan
 
Parasitology 2024 | Microbes with Morgan
Parasitology 2024 | Microbes with MorganParasitology 2024 | Microbes with Morgan
Parasitology 2024 | Microbes with MorganMargie Morgan
 
Mycobacteriology update 2024 Margie Morgan.ppt
Mycobacteriology update 2024 Margie Morgan.pptMycobacteriology update 2024 Margie Morgan.ppt
Mycobacteriology update 2024 Margie Morgan.pptMargie Morgan
 
Mycology Update February 2024 Microbes with Morgan
Mycology Update February 2024 Microbes with MorganMycology Update February 2024 Microbes with Morgan
Mycology Update February 2024 Microbes with MorganMargie Morgan
 
Web Bacteriology 2023
Web Bacteriology 2023Web Bacteriology 2023
Web Bacteriology 2023Margie Morgan
 
Mycology Update 2023
Mycology Update 2023Mycology Update 2023
Mycology Update 2023Margie Morgan
 
Mycobacteriology Update 2023
Mycobacteriology Update 2023Mycobacteriology Update 2023
Mycobacteriology Update 2023Margie Morgan
 
Mycobacteriology 2022
Mycobacteriology 2022Mycobacteriology 2022
Mycobacteriology 2022Margie Morgan
 
Bacteriology Update 2021 (Part 2.)
Bacteriology Update 2021 (Part 2.)Bacteriology Update 2021 (Part 2.)
Bacteriology Update 2021 (Part 2.)Margie Morgan
 
Bacteriology Update 2021 (Part 1.)
Bacteriology Update 2021 (Part 1.)Bacteriology Update 2021 (Part 1.)
Bacteriology Update 2021 (Part 1.)Margie Morgan
 
Mycobacteriology 2021
Mycobacteriology 2021Mycobacteriology 2021
Mycobacteriology 2021Margie Morgan
 
Mycology Update 2021
Mycology Update 2021Mycology Update 2021
Mycology Update 2021Margie Morgan
 
Bacteriology Update 2020
Bacteriology Update 2020Bacteriology Update 2020
Bacteriology Update 2020Margie Morgan
 
Antibiotic Sensitivity Testing 2020 Update
Antibiotic Sensitivity Testing 2020 Update Antibiotic Sensitivity Testing 2020 Update
Antibiotic Sensitivity Testing 2020 Update Margie Morgan
 

More from Margie Morgan (20)

Susceptibility Update 2024 | Microbes with Morgan
Susceptibility Update 2024 | Microbes with MorganSusceptibility Update 2024 | Microbes with Morgan
Susceptibility Update 2024 | Microbes with Morgan
 
WEB BACTERIOLOGY 2024 | Microbes With Morgan
WEB BACTERIOLOGY 2024 | Microbes With MorganWEB BACTERIOLOGY 2024 | Microbes With Morgan
WEB BACTERIOLOGY 2024 | Microbes With Morgan
 
Parasitology 2024 | Microbes with Morgan
Parasitology 2024 | Microbes with MorganParasitology 2024 | Microbes with Morgan
Parasitology 2024 | Microbes with Morgan
 
Mycobacteriology update 2024 Margie Morgan.ppt
Mycobacteriology update 2024 Margie Morgan.pptMycobacteriology update 2024 Margie Morgan.ppt
Mycobacteriology update 2024 Margie Morgan.ppt
 
Mycology Update February 2024 Microbes with Morgan
Mycology Update February 2024 Microbes with MorganMycology Update February 2024 Microbes with Morgan
Mycology Update February 2024 Microbes with Morgan
 
Web Bacteriology 2023
Web Bacteriology 2023Web Bacteriology 2023
Web Bacteriology 2023
 
Gram Stain 2023
Gram Stain 2023Gram Stain 2023
Gram Stain 2023
 
Susceptibility 2023
Susceptibility 2023Susceptibility 2023
Susceptibility 2023
 
Mycology Update 2023
Mycology Update 2023Mycology Update 2023
Mycology Update 2023
 
Mycobacteriology Update 2023
Mycobacteriology Update 2023Mycobacteriology Update 2023
Mycobacteriology Update 2023
 
Mycology 2022
Mycology 2022Mycology 2022
Mycology 2022
 
Mycobacteriology 2022
Mycobacteriology 2022Mycobacteriology 2022
Mycobacteriology 2022
 
Bacteriology Update 2021 (Part 2.)
Bacteriology Update 2021 (Part 2.)Bacteriology Update 2021 (Part 2.)
Bacteriology Update 2021 (Part 2.)
 
Bacteriology Update 2021 (Part 1.)
Bacteriology Update 2021 (Part 1.)Bacteriology Update 2021 (Part 1.)
Bacteriology Update 2021 (Part 1.)
 
Gram Stains 2021
Gram Stains 2021Gram Stains 2021
Gram Stains 2021
 
Mycobacteriology 2021
Mycobacteriology 2021Mycobacteriology 2021
Mycobacteriology 2021
 
Mycology Update 2021
Mycology Update 2021Mycology Update 2021
Mycology Update 2021
 
Parasitology 2020
Parasitology 2020Parasitology 2020
Parasitology 2020
 
Bacteriology Update 2020
Bacteriology Update 2020Bacteriology Update 2020
Bacteriology Update 2020
 
Antibiotic Sensitivity Testing 2020 Update
Antibiotic Sensitivity Testing 2020 Update Antibiotic Sensitivity Testing 2020 Update
Antibiotic Sensitivity Testing 2020 Update
 

Recently uploaded

Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and ModificationsMJDuyan
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfSherif Taha
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.MaryamAhmad92
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxcallscotland1987
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docxPoojaSen20
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsMebane Rash
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentationcamerronhm
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701bronxfugly43
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfNirmal Dwivedi
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin ClassesCeline George
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptxMaritesTamaniVerdade
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...ZurliaSoop
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Association for Project Management
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 

Recently uploaded (20)

Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 

Virology Review

  • 2. Diagnostic techniques used in the Virology Laboratory
  • 3. Laboratory diagnosis  Direct antigen detection from lesions  Direct Fluorescent antibody (DFA) stain  Collect cells from base of vesicular lesion  Stain with Fl antibody specific for HSV and/or VZV  Look for fluorescent cells using fluorescence microscope  Can provide a HSV and VZV diagnosis  More sensitive and specific than Tzanck prep (DFA 80% vs. Tzanck 50%)  Tzanck prep= Giemsa stain/examine for multinucleated giant cells of Herpes virus Tzanck
  • 4. Rapid detection of viral antigens  Enzyme immunoassay –  Antigen/antibody complex formed – then combined with color forming compound  Detection of non-culturable viruses – such as Rotavirus  Detection of Influenza A and B , and Respiratory syncytial virus (RSV)  Membrane EIA Liquid/well EIA
  • 5. Molecular Detection  Amplification of DNA or RNA  Rapid results  Exceed sensitivity of culture  Standard of practice for detecting respiratory viruses  Standard of practice for HSV and Enterovirus detection in CSF  Culture <=20% PCR >=90%  CMV quantitative assays in transplantation  Hepatitis B and C detection and viral load  HIV viral load  Test of diagnosis not cure – can retain DNA/RNA for 7 – 30 days after initial diagnosis
  • 6. Viral Cell Culture  Viral cell culture  Inner wall coated with monolayer of cells covered with liquid maintenance media  Primary cell lines – directly from animal into tube (Rhesus monkey kidney-RMK)  Diploid cell lines– Can survive 20 – 50 passes into new vials – fibroblast cells MRC-5-(Microbiology Research Council 5) human diploid fibroblasts  Continuous cell lines – can survive continuous passage into new vials, usually of tumor lineage, HEp-2 and HeLa
  • 7. Viral Cell culture  Cytopathic effect – CPE  Appearance of cell monolayer after being infected with a virus  Specific for each virus type
  • 8. Spin Down Shell Vial Method Designed to speed up virus recovery Cells are on the round coverslip Specimen put into vial Centrifugation to induce virus invasion Incubate 24 - 72 hours DFA stain cells on coverslip with early antigen for virus of interest Cover slip
  • 9. Specimen collection and transport  Viral transport media- Hanks balanced salt solution with antibiotics, needed for the transport of lesions, mucous membranes and throats to the laboratory I
  • 10. Which viruses will survive the trip to the laboratory?  Most likely viable - HSV  Intermediate  Adenovirus  Influenza A and B  Enterovirus  Least likely to survive  Respiratory Syncytial Virus (RSV)  Cytomegalovirus (CMV)  Varicella Zoster virus (VZV)  Amplification preferred due to survival issue
  • 11. Which viruses grow the fastest in conventional cell culture?  Fast (>=24 hours)  HSV  Intermediate (5 -7 days)  Adenovirus Enterovirus  Influenzae VZV  Slow (10 - 14 days)  RSV  Slowest (14 - 21 days)  CMV  Molecular superior for slow growers
  • 13. Herpes Viruses  Double stranded DNA virus  Eight human Herpes viruses  Herpes simplex 1  Herpes simplex 2  Varicella Zoster  Epstein Barr  Cytomegalovirus  Human Herpes 6, 7, and 8  Latent infection with recurrent disease is the hallmark of the Herpes viruses  Latency occurs within small numbers of specific kinds of cells, the cell type is different for each Herpes virus
  • 14. Herpes simplex virus 1 and 2  Transmission: direct contact/secretions  Latency: dorsal root ganglia *  Disease –  Gingivostomatitis  Herpes labialis  Ocular  Encephalitis  Neonatal  Disseminated in immune suppressed  Therapy – Acyclovir, Valacyclovir
  • 15. Herpes virus diagnosis Herpes 1 & 2 do well in culture Grow within 24-48 hrs in Human diploid fibroblast cells (MRC-5) / Observe for characteristic CPE  Antigen detection by direct fluorescent staining of cells obtained from vesicular lesions  Amplification methods for diagnosis  Cytology/Histology - intra nuclear inclusions, multinucleated giant cells  Serology – Most helpful to detect past infection
  • 16. Negative fibroblast cell Culture -uninfected cells HSV infected monolayer Rounded cells throughout the monolayer in cell culture Multinucleated Giant Cells of Herpes Simplex in tissue histology
  • 17. Varicella Zoster Virus  Transmission: close contact  Latency: dorsal root ganglia  Diseases:  Chickenpox (varicella)  Shingles (zoster – latent infection)  Chicken pox +/- eliminated due to effective vaccine program – most serious disease occurs in immune suppressed or adult patient – can progress to pneumonia and encephalitis  Histology – Herpes simplex multi-nucleated giant cells like those of  Serology useful for immune status check  Amplification useful for disease diagnosis
  • 18. Varicella-Zoster Diagnosis In cell culture – Limited # of Foci 5- 7 days to develop Sandpaper look to the Background Scattered rounded cells Younger wet vesicular lesions area the best for culture and/or molecular testing
  • 19. Cytomegalovirus (CMV)  Transmitted by blood transfusion , vertical and horizontal transmission to fetus, close contact  Latency: Macrophages  Disease: Asymptomatic in most individuals infected  Congenital – most common cause  Perinatal  Immunocompromised – Primary disease most serious  Diagnosis: Cell culture CPE (Human diploid fibroblast , PCR and quantitative PCR  Histopathology: Intranuclear and intracytoplasmic inclusions “Owl Eye” Inclusions
  • 20. CMV pneumonia with viral inclusions CMV infected fibroblast monolayer - Focal grape like clusters of rounded cells
  • 21. Epstein Barr virus (EBV)  Transmission - close contact, saliva  Latency - B lymphocytes  Diseases include:  Infectious mononucleosis  Lymphoreticular disease  Oral hairy leukoplakia  Burkitt’s lymphoma  Nasopharyngeal Carcinoma  1/3 Hodgkin’s lymphoma  Unable to grow in cell culture  Serology and PCR methods for diagnosis
  • 22. EBV Serodiagnosis using the Heterophile Antibody  Heterophile antibodies (HA) react with antigens phylogenetically unrelated to the antigenic determinants against which they were raised  HA secondary to EBV are detected by the ability to react with horse or cattle rbcs (theory of the Monospot test)  HA rise in the first 2 - 3 weeks of EBV infection, then rapidly fall at @ 4 weeks  Cannot be used in children < 4 years of age
  • 23. VCA = viral capsid antibody EBNA = Epstein Barr nuclear antigen EA = early antigen
  • 24. Human Herpes virus 6, 7 & 8  HH6  Roseola [sixth disease]  6m-2yr high fever & rash  HH7  CMV like Disease  HH8  Kaposi’s sarcoma  Castleman’s disease Onion skin of Castleman disease
  • 26. Adenovirus     DNA - non enveloped/ icosahedral virus Latent: lymphoid tissue Transmission: Respiratory and fecal-oral route Diseases:  Adenovirus type 14 – new virulent respiratory strain / pneumonia  Pharyngitis (year round epidemics)  Gastroenteritis in children  Adenovirus types 40 & 41  Keratoconjuctivitis  Disseminated infection in transplant patients  Hemorrhagic cystitis in immune suppressed
  • 27. Adenovirus Round cells with stranding  Diagnosis  Conventional cell culture (CPE)  2-5 days with round cells connected by strands – Grows best in Heteroploid continuous passage cell lines (HeLA, Hep-2)  Amplification  Histology - Intranuclear inclusions / smudge cells  Stool EIA for enteric infections  Antigen detection – staining respiratory cells by DFA for Respiratory infections  PCR – has become the standard of practice  Supportive treatment – no specific viral therapy
  • 29. Parvoviridae – Parvovirus The smallest known viruses!
  • 30. Parvovirus  DNA virus  Parvovirus B19 Slapped face appearance of fifth disease  erythema infectiosum (Fifth disease)  fetal infection and stillbirths  aplastic crisis in patients with chronic hemolytic anemia and AIDS  Histology - virus effects mitotically active erythroid precursor cells in bone marrow  Molecular and Serology methods for diagnosis
  • 32. Pap smear Papillomavirus  Diseases:          skin and anogenital warts, benign head and neck tumors, cervical and anal intraepithelial neoplasia and cancer HPV types 16 and 18 = 70% Cervical CA HPV types 6 and 11 = 90% Genital warts Pap Smear for detection Hybrid capture DNA probe for detection and typing PCR – FDA approved platforms for detection/typing Guardasil vaccine = To guard against HPV 6,11,16,18
  • 33. Polyomavirus Giant Glial Cells of JCV  JC virus [John Cunningham]  Cause of Progressive multifocal leukoencephalopathy   Encephalitis of immune suppressed Destroys oligodendrocytes in brain  BK virus  Causes latent virus infection in kidney  Progression due to immune suppression  Hemorrhagic cystitis  Histology/PCR for diagnosis
  • 35. Hepatitis B virus     Enveloped DNA – Hepadna virus Virion called Dane particle Surface Ag (HBsAg)- Australian Ag Clinical Disease  90% acute  1% fulminant  9% chronic  Carrier state …….Hepatic cell carcinoma
  • 36. Hepatitis B Serology  Surface Antigen Positive  Active Hepatitis B or Chronic Carrier  Do Hep B Quantitation  Do Hep e antigen – Chronic and “bad”  Core Antibody Positive  Immune due to prior infection, acute infection or chronic carrier  Surface Antibody Positive  Immune due to prior infection or vaccine
  • 38. Hepatitis C virus  Spread parenterally - drug abuse, blood products, poorly sterilized medical equipment, sexual  Effects only humans and chimpanzees  Seven major genotypes  Acute self limited disease to start with progressive disease that mainly affects the liver  Infection persists in 80%  20 - 30 % develop cirrhosis  Associated with hepatocellular CA  Require liver transplantation
  • 39. Hepatitis C  Diagnosis:  Hep C antibody test  If antibody positive do:  RNA qualitative or quantitative assay for viral load  Requires Genotyping for proper therapy  Type 1 most common  No vaccine – Antivirals currently in clinical trials that can cure a large % of infected
  • 40. Flaviviruses – Mosquito borne  St. Louis  Dengue – breakbone fever  Yellow fever  West Nile Fever, Headache, Muscle weakness Various species Mosquitoes  Serology / PCR
  • 42. Enteroviruses  Diverse group of > 60 viruses  infections occur most often in summer and fall  Polio virus - paralysis         Salk vaccine Inactive Polio Vaccine (IPV)**  Sabine vaccine Live Attenuated Vaccine (OPV) Coxsackie A – Herpangina Coxsackie B – Pericarditis/Myocarditis Enterovirus – Aseptic meningitis in children, hemorrhagic conjunctivitis Echovirus – various infections, intestine Rhinoviruses – common cold Grow in cell culture (Diploid mixed cell – Primary Monkey Kidney) PCR superior for diagnosis of meningitis (CSF)
  • 43. CPE of Enterovirus Teardrop and kite like cells in Rhesus Monkey Kidney cell culture
  • 44. Hepatitis A  Fecal – oral transmission  Can be cultured but not reliably  Usually – short incubation, abrupt onset, low mortality, no carrier state  Travel  Diagnosis – serology, IgM positive in early infection  Vaccine available
  • 46. Influenza A  Segmented RNA genome  Hemagglutinin and Neuraminidase glycoproteins spikes on outside of viral capsid  Give Influenza A the H and N designations – such as H1N1 and H3N2  Antigenic drift - minor change in the amino acids of either the H or N glycoprotein  Cross antibody protection will still exist so an epidemic will not occur  Antigenic shift - genome re assortment with a “new” virus created/usually from a bird or animal/ this could create a potential pandemic  H5N1 = Avian Influenza  H1N1 = 2009 Influenza A
  • 47. Influenzae A Disease: fever, malaise …. death Diagnosis  Cell culture obsolete [RMK]  Enzyme immunoassay on paper membrane can be used in outpatient setting – Rapid but low sensitivity (60%) and can have specificity issues in off season.  Amplification (PCR) gold standard for Influenza Detection  Treatment: Amantadine and Tamiflu  Seasonal variation in susceptibility  Vaccinate to prevent  Influenza B   Milder form of Influenza like illness Usually <=10% of cases /year
  • 48. Paramyxoviruses – SS RNA Measles Parainfluenza 1,2,3,4 Mumps Respiratory Syncytial Virus Human Metapneumovirus
  • 49. Measles  Measles  Fever, Rash, Dry Cough, Runny Nose, Sore throat, inflamed eyes (photosensitive)  Respiratory spread - very contagious  Koplik’s spots – bluish discoloration inner lining of the cheek  Subacute sclerosing panencephalitis [SSPE]  Rare chronic degenerative neurological disease  Persistent infection with mutated measles virus due to lack of immune response  Diagnosis: Clinical symptoms and Serology  Vaccinate – MMR (Measles, Mumps, Rubella) vaccine  Treatment: Immune globulin, vitamin A
  • 50. Parainfluenzae  Types 1,2,3, and 4  Person to person spread  Disease:  Upper respiratory tract infection in adults – more serious in immune suppressed  Croup, bronchiolitis and pneumonia in children  Heteroploid cell lines (Hep-2) for culture  PCR methods are the gold standard  Supportive therapy
  • 51. Mumps  Person to person contact  Classic infection is Parotitis, but can cause infections in other sites: T
  • 52. Respiratory Syncytial Virus  Transmission:  Hand contact and respiratory droplets  Respiratory disease - from common cold to pneumonia, bronchiolitis to croup, serious disease in immune suppressed  Classic disease:  Young infant with bronchiolitis  Specimen: Naso-phayrngeal, nasal swab, nasal lavage  Diagnosis: EIA, cell culture (heteroploid cell lines), PCR is standard practice  Treatment: Supportive, ribavirin
  • 53. Classic CPE = Syncytium formation In heteroploid cell line Respiratory syncytial virus CPE Histology
  • 54. Human Metapneumovirus  1st discovered in 2001 – community acquired respiratory tract disease in the winter  Common in young children – but can be seen in all age groups  @95% of cases in children <6 years of age  Upper respiratory tract disease  2nd only to RSV in the cause of bronchiolitis  Will not grow in cell culture  Amplification (PCR) for detection  Specimen: Nasal swab or NP  Treatment: Supportive
  • 56. Rotavirus  Winter - spring season  6m-2 yrs of age,  Gastroenteritis with vomiting and fluid loss – most common cause of severe diarrhea in children  Fecal – oral spread  Major cause of death in 3rd world  Diagnosis – cannot grow in cell culture  Enzyme immunoassay, PCR  Vaccine available
  • 58. Norovirus  Spread by contaminated food and water, feces & vomitus – takes <=20 virus particles to cause infection – so highly contagious  Tagged the “Cruise line virus” – numerous reported food borne epidemics on land and sea  Leading cause of epidemic gastroenteritis – more virulent GII.4 Sydney since spring 2012  Fluid loss from vomiting  Disease course usually limited, 24-48 hours  PCR for diagnosis  Cannot be grown in cell culture
  • 59. Retrovirus RNA Virus/Reverse Transcriptase Enzyme Human Immunodeficiency Virus HIV
  • 60. Human Immunodeficiency virus  CD4 primary receptor to gain entry for HIV into the lymphocyte  Reverse transcriptase enzyme converts genomic RNA into DNA  Transmission - sexual, blood and blood product exposure, perinatal  Non infectious complications:  Lymphoma, KS, Anal cell CA, non Hodgkins Lymphoma
  • 61. HIV  Diagnosis  Antibody EIA with Western Blot confirmation  Antibody test alone is NOT sufficient  Western blot detects gp160/gp120 (envelope proteins), p 24 (core), and p41(reverse trans)  Must have at least 2 bands on Western blot to confirm the diagnosis of HIV  Positive patients require additional testing  HIV RNA/DNA quantitation >= 100 copies  Resistance Testing – report subtype  Most isolates in USA type B  Monitor CD4 counts for infection severity
  • 62. HIV infectious complications  Non-compliant patients or newly diagnosed        Pneumocystis C. neoformans and Histoplasma TB/Mycobacterium avium complex Microsporidia and Cryptosporidium Hepatitis B Hepatitis C STD’s – Syphilis, GC, Chlamydia  Syphilis rate high (mucosal contact)
  • 64. Rubella  Respiratory transmission  Known as the “Three day measles” – German measles  Congenital rubella – occurs in a developing fetus of a pregnant women who has contracted Rubella, highest % in the first trimester pregnancy  Diagnosis - Serology in combination with clinical symptoms – Rash, low fever, cervical lymphadenopathy  Live attenuated vaccine (MMR) to prevent
  • 66. Hantavirus  USA outbreak in four corners (NM,AZ,CO,UT) Indian reservation in 1993 brought attention to this virus  Source - Urine and secretions of wild field mice  Deer mouse and cotton rat  Myalgia, headache, cough and respiratory failure  Found in states west of the Mississippi River  Diagnosis by serology/ no therapy
  • 67. Poxviruses Smallpox virus (Variola virus) Vaccinia virus
  • 68. Smallpox  Smallpox virus is also known as the Variola virus  Vaccinia virus = vaccine strain used in Smallpox vaccine, it is immunologically related to smallpox, Vaccinia can cause disease in the immune suppressed, which prevents vaccinated this population  Last case of Smallpox - Somalia in 1977  Disease begins as maculopapular rash and progresses to vesicular rash - all lesions in same stage on a body area – rash moves from central body outward  Potential agent of Bioterrorism  Any potential cases directly reported to public health department – they will investigate and diagnose
  • 69. Chickenpox vs Smallpox lesions Chicken pox – Lesions of different stage of development Smallpox – all lesions same stage of development
  • 70. Rhabdoviruses bullet shaped RNA virus Rabies virus
  • 71. Rabies  Worldwide in animal populations  Bat and raccoons primary reservoir in US  Dogs in 3rd world countries  Post exposure shots PRIOR to the development of symptoms prevent infection  Rabies is a neurologic disease – classic sympton is salivation, due to paralysis of throat muscles  Detection of viral particles in the brain by Histologic staining known as Negri bodies  Public health department should be contacted to assist with diagnosis
  • 72. Rabies virus particles EM showing the bullet shaped virus Negri bodies – intracytoplasmic